Tencent Holdings Limited is a leading internet service provider based in Shenzhen, China, known for its extensive range of value-added services, including online games, social networking, financial technology, and online advertising. Founded in 1998, Tencent operates major platforms such as WeChat and QQ, which facilitate communication, entertainment, and e-commerce for millions of users. The company is recognized as the world's largest video game publisher, with popular titles like Honor of Kings in its portfolio. In addition to its core services, Tencent is involved in the production and distribution of films and television programs, as well as software development and digital content licensing. With a focus on user-oriented strategies, Tencent continues to adapt and expand its offerings, positioning itself as a vital part of daily life for many consumers in China and beyond.
President, International Partnerships (North America)
Martin Lau
President
Jeffrey Li
Managing Partner
Alvin Liu
Co-Founder
Steven Ma
SVP
Huateng Ma
Co-Founder, Chairman and CEO
Danying Ma
Managing Director
Bo Wang
Vice President, Tencent Games
Ye Wang
Associate Director, Global Data Intelligence and Data Service, IEG
Yao Xia
Executive Director
Levin Yao
Managing Director, Tencent Investment
Wenlei Zhuang
Vice President of Tencent Cloud and Head of Tencent Cloud Strategic Investment
phil mu
Chief Investment Officer
Dowson Tong
President of Social Network Group, Senior Executive Vice President
Past deals in Data Mining
Zhipu AI
Venture Round in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
Zhipu AI
Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
Zhipu AI
Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
Qumata
Series A in 2022
Qumata specializes in life and health insurance underwriting by utilizing digital data to assess the risk of over 800 medical conditions. The company's innovative approach streamlines the application process, reducing the need for lengthy questionnaires and medical visits, thereby saving applicants significant time. Qumata aims to enhance the underwriting experience for insurers while maintaining accuracy, ultimately enabling them to discover new revenue opportunities. Through its platform, Qumata is setting a new standard in the insurance industry by improving efficiency and customer satisfaction in the underwriting process.
Vision Medicals
Series D in 2021
Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.
WakeData
Series B in 2021
WakeData is a provider of comprehensive big data services designed for offline enterprises. The company specializes in integrating online and offline data to enhance operational efficiency and facilitate digital transformation for its clients. By leveraging technologies such as WiFi probes, camera face recognition, and user online behavior analysis, WakeData enables businesses to optimize their customer management and marketing strategies. This approach shifts enterprise IT from merely supporting business operations to driving them, transforming traditional marketing methods into targeted digital campaigns. Through its innovative solutions, WakeData aims to unlock the full value of offline data, contributing to more effective decision-making and management in the retail sector.
Shumei Technology
Series D in 2021
Shumei Technology is an information technology company that provides an AI-based business risk control for companies and organizations. It specializes in SaaS, AI-based risk control service network, data-driven products, and bigdata. The company was founded in 2015 and headquartered in Wangjing, Beijing, China.
Vision Medicals
Series C in 2021
Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.
Medbanks
Series E in 2020
Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.
Shumei Technology
Series C in 2020
Shumei Technology is an information technology company that provides an AI-based business risk control for companies and organizations. It specializes in SaaS, AI-based risk control service network, data-driven products, and bigdata. The company was founded in 2015 and headquartered in Wangjing, Beijing, China.
Synyi
Series C in 2019
Synyi is a provider of an artificial intelligence-powered medical data platform designed to enhance medical research, healthcare, and patient services through big data applications. The company specializes in utilizing natural language processing technology to structure and standardize medical texts, employing techniques such as lexical, syntactic, and semantic analysis. This enables hospitals to implement smart medical systems that improve access to critical information. The core team at Synyi consists of experts from prestigious universities and leading companies, with significant achievements in artificial intelligence and medical informatics. Their work has been recognized in numerous national and municipal projects, along with the publication of over 20 papers in top international journals and presentations at major medical conferences.
Medbanks
Series D in 2018
Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.
Citrine Informatics
Convertible Note in 2018
Citrine Informatics, Inc. is a technology company that specializes in artificial intelligence and machine learning to enhance materials development. Founded in 2013 and headquartered in Redwood City, California, with an additional office in Pittsburgh, the company operates a platform that aggregates and analyzes extensive datasets related to materials, chemicals, and devices. This platform aims to streamline research and development, manufacturing, and supply chain processes for organizations involved in producing physical products. By employing data science and machine learning, Citrine Informatics accelerates the discovery of new materials and helps identify defects early in the research process, thereby improving product design and development efficiency across various sectors, including energy, aerospace, and electronics.
Stratifyd
Series A in 2017
Stratifyd, Inc., also known as Taste Analytics LLC, operates an AI-powered analytics platform that helps organizations derive actionable insights from both structured and unstructured data sources. Founded in 2012 and based in Charlotte, North Carolina, with an additional office in Durham, the platform is particularly focused on enhancing the customer feedback loop by analyzing data from call centers, surveys, product reviews, and CRM systems. This enables enterprises to identify trends, patterns, and correlations, facilitating improved decision-making across marketing, product development, and customer support. Stratifyd's solution assists businesses in increasing customer retention, enhancing products and services, and ultimately driving revenue growth. The company serves a diverse clientele, including Fortune 50 companies and various Fortune 1000 organizations across multiple industries, with deployment options available on both internal enterprise clouds and secure public cloud environments.
Transwarp
Series C in 2017
Transwarp develops big data software technologies for enterprises. The company's cloud-based platform offers an integrated, one-stop data processing and cloud operating system to explore the applications of big data infrastructure in enterprises, enabling enterprises to store, manage and analyze data.
Yonghong Tech
Series C in 2016
Yonghong Tech is a Chinese high-tech company founded in February 2012, focused on data harnessing and the extraction of data value. The company offers a range of services, including big data, business intelligence, and commercial intelligence analysis, aimed at helping enterprise users identify risks and optimize their operations. Yonghong Tech's product line includes the Yonghong Z-Suite, among others, which are designed to simplify data analysis and enhance decision-making processes. Additionally, the company provides professional consulting and system construction services across various sectors, including broadcasting, telecommunications, mobile, security, and government. Yonghong Tech holds numerous patents in areas such as distributed computing, cloud computing, and data processing, underscoring its commitment to advancing technology in the data analytics field.
Medbanks
Series B in 2016
Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.
iCarbonX
Series A in 2016
iCarbonX aimed at building a ecosystem of digital life based on the combination of consumers’ big life data, internet and artificial intelligence. The individual health steward, created by the common efforts of artificial intelligence team and top biotechnology,will lead a healthy life through the digital life ecosystem. The main founding team of the company was from the BGI Tech. It was deeply experienced in omics technology, mobile health, medical service, biological data analysis, artificial intelligence and data mining,etc. They will create the first and also most professional data collection platform of millions of health data in China, combine the best biotechnology and the top team of artificial intelligence, and integrate the advantages of artificial intelligence into the abundant analyses and applications of big life data through data mining and machine learning.
M4Jam
Private Equity Round in 2015
M4JAM is a micro jobbing platform based in Johannesburg, South Africa, that connects businesses with local communities through gig technology. By facilitating access to informal markets, M4JAM enables a diverse range of organizations, including brands, start-ups, SMEs, NGOs, and governments, to tap into a large community of individuals available for on-demand tasks. The platform empowers users by rewarding them for completing various assignments, thereby fostering economic upliftment and creating valuable data assets for businesses. Through its innovative approach, M4JAM helps companies navigate the challenges of a rapidly changing environment by enhancing their agility and relevance in the marketplace.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.